Christopher K. Mirabelli

5.4k total citations · 1 hit paper
73 papers, 4.6k citations indexed

About

Christopher K. Mirabelli is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Christopher K. Mirabelli has authored 73 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 27 papers in Oncology and 21 papers in Organic Chemistry. Recurrent topics in Christopher K. Mirabelli's work include DNA and Nucleic Acid Chemistry (18 papers), Metal complexes synthesis and properties (17 papers) and Cancer therapeutics and mechanisms (16 papers). Christopher K. Mirabelli is often cited by papers focused on DNA and Nucleic Acid Chemistry (18 papers), Metal complexes synthesis and properties (17 papers) and Cancer therapeutics and mechanisms (16 papers). Christopher K. Mirabelli collaborates with scholars based in United States and United Kingdom. Christopher K. Mirabelli's co-authors include Stanley T. Crooke, Michael R. Mattern, Randall K. Johnson, F H Drake, Leo F. Faucette, C. Frank Bennett, Huai En Huang Chan, Richard Woessner, H F Bartus and Cheng-Hsiung Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Christopher K. Mirabelli

73 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.

1992 525 citations C. Frank Bennett, Huai En Huang Chan et al. Molecular Pharmacology profile →

Peers

Countries citing papers authored by Christopher K. Mirabelli

Since Specialization

Citations

This map shows the geographic impact of Christopher K. Mirabelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher K. Mirabelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher K. Mirabelli more than expected).

Fields of papers citing papers by Christopher K. Mirabelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher K. Mirabelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher K. Mirabelli. The network helps show where Christopher K. Mirabelli may publish in the future.

Co-authorship network of co-authors of Christopher K. Mirabelli

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher K. Mirabelli. A scholar is included among the top collaborators of Christopher K. Mirabelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher K. Mirabelli. Christopher K. Mirabelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lipid Membrane Permeability of 2′-Modified Derivatives of Phosphorothioate Oligonucleotides 1994 ·Journal of Pharmaceutical Sciences ·Jeffrey A. Hughes, C. Frank Bennett, P. Dan Cook, Charles J. Guinosso, Christopher K. Mirabelli, R. L. Juliano	15
2	Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. breakdown → 1992 ·Molecular Pharmacology ·C. Frank Bennett, (unknown), Huai En Huang Chan, (unknown), Christopher K. Mirabelli	525
3	Antiarthritic and supressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents 1990 ·Journal of Medicinal Chemistry ·Alison M. Badger, David A. Schwartz, Donald Picker, (unknown), Fontaine C. Bradley, (unknown), Michael J. DiMartino, (unknown), Christopher K. Mirabelli	41
4	Cytotoxicity and antitumor activity of some tetrahedral bis(diphosphino)gold(I) chelates 1990 ·Journal of Medicinal Chemistry ·Susan J. Berners‐Price, Gerald R. Girard, David T. Hill, Blaine M. Sutton, Penelope S. Jarrett, Leo F. Faucette, Randall K. Johnson, Christopher K. Mirabelli, Peter J. Sadler	101
5	Induction of non-specific suppressor cells in normal lewis rats by a novel azaspirane SK&F 105685 1990 ·Journal of Autoimmunity ·Alison M. Badger, Andrew King, James E. Talmadge, David A. Schwartz, Donald Picker, Christopher K. Mirabelli, Nabil Hanna	22
6	Gold(I) efflux from auranofin-treated red blood cells 1990 ·Biochemical Pharmacology ·C. Frank Shaw, Anvarhusein A. Isab, (unknown), Christopher K. Mirabelli	19
7	Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II 1989 ·Biochemistry ·Fred H. Drake, Glenn A. Hofmann, H F Bartus, Michael R. Mattern, Stanley T. Crooke, Christopher K. Mirabelli	362
8	Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes 1989 ·International Journal of Immunopharmacology ·Alison M. Badger, Michael J. DiMartino, James E. Talmadge, Donald Picker, David A. Schwartz, (unknown), Christopher K. Mirabelli, Nabil Hanna	17
9	The mechanism of acute cytotoxicity of triethylphosphine gold(I) complexes 1989 ·Toxicology and Applied Pharmacology ·Glenn D. Hoke, Glenn F. Rush, Christopher K. Mirabelli	18
10	Intestinal 5-Fluorouracil Absorption: Use of Ussing Chambers to Assess Transport and Metabolism 1988 ·Pharmaceutical Research ·Philip L. Smith, Christopher K. Mirabelli, Joseph D. Fondacaro, (unknown), John G. Dent	38
11	Antimicrobial and anticancer activity of tetrahedral, chelated, diphosphine silver(I) complexes: Comparison with copper and gold 1988 ·Journal of Inorganic Biochemistry ·Susan J. Berners‐Price, Randall K. Johnson, (unknown), Leo F. Faucette, Christopher K. Mirabelli, Peter J. Sadler	97
12	Thiol competition for Et3PAuS-albumin: a nonenzymatic mechanism for Et3PO formation 1987 ·Journal of Inorganic Biochemistry ·(unknown), C. Frank Shaw, (unknown), Christopher K. Mirabelli, Stanley T. Crooke	43
13	Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds 1987 ·Journal of Medicinal Chemistry ·Christopher K. Mirabelli, David T. Hill, Leo F. Faucette, Francis L. McCabe, Gerald R. Girard, D. B. BRYAN, Blaine M. Sutton, (unknown), Stanley T. Crooke, Randall K. Johnson	138
14	Antiarthritic and immunoregulatory activity of spirogermanium. 1986 ·Journal of Pharmacology and Experimental Therapeutics ·Michael J. DiMartino, (unknown), A M Badger, Katharine A. Muirhead, Christopher K. Mirabelli, Nazeeh Hanna	41
15	金複合体オウラノフィンのマウスしゅようモデルを用いてのin vivo抗しゅよう活性およびin vitroの細胞毒性 1985 ·Cancer Research ·Christopher K. Mirabelli, R K Johnson, (unknown), Leo F. Faucette, Katharine A. Muirhead, Stanley T. Crooke	2
16	Effects of DNA superhelical changes induced by ethidium bromide on the DNA-degrading activity of two antitumor antibiotics, bleomycin and phleomycin. 1983 ·PubMed ·Cheng-Hsiung Huang, Christopher K. Mirabelli, Seymour Mong, Stanley T. Crooke	12
17	Intermolecular cross-linking of DNA through bifunctional intercalation of an antitumor antibiotic, luzopeptin A (BBM-928A). 1983 ·PubMed ·Cheng-Hsiung Huang, Christopher K. Mirabelli, Seymour Mong, Stanley T. Crooke	39
18	Bleomycin and talisomycin sequence-specific strand scission of DNA: a mechanism of double-strand cleavage. 1982 ·PubMed ·Christopher K. Mirabelli, Albert C.W. Ting, Cheng-Hsiung Huang, Seymour Mong, Stanley T. Crooke	61
19	Comparison of the sequences at specific sites on DNA cleaved by the antitumor antibiotics talisomycin and bleomycin. 1982 ·PubMed ·Christopher K. Mirabelli, Wanda G. Beattie, Cheng-Hsiung Huang, Archie W. Prestayko, Stanley T. Crooke	18
20	Comparison of DNA damage and single- and double-strand breakage activities on PM-2 DNA by talisomycin and bleomycin analogs. 1980 ·PubMed ·Christopher K. Mirabelli, Cheng-Hsiung Huang, Stanley T. Crooke	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact